Sign in

CIK 0001842295 · Non-accelerated filer<br>Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6508505070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Executive or director change · Regulation FD disclosure
  14. 4 Insider Changes in Ownership
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Insider Changes in Ownership
  19. 144 Insider Sale of Securities
  20. 4 Insider Changes in Ownership

Page 2 of 12 · 224 filings